Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 2

Therapeutics

Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
Biotechnology | Disease | Neurology | Therapeutics | Women's Health

Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children

On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…

Read More Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in childrenContinue

Despite global decrease, Chagas disease is rising in non-endemic regions
Biotechnology | Diagnostics | Disease | Therapeutics

Despite global decrease, Chagas disease is rising in non-endemic regions

On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…

Read More Despite global decrease, Chagas disease is rising in non-endemic regionsContinue

WHO publishes new global research agenda to strengthen paediatric clinical trials
Clinical Research | Disease | Infectious Disease | Therapeutics | WHO | Women's Health

WHO publishes new global research agenda to strengthen paediatric clinical trials

On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…

Read More WHO publishes new global research agenda to strengthen paediatric clinical trialsContinue

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
Biotechnology | FDA | Medicine | Therapeutics

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…

Read More Lilly and U.S. government agree to expand access to obesity medicines to millions of AmericansContinue

Oxford scientists capture genome’s structure in unprecedented detail
Biotechnology | Diagnostics | Genomics | Therapeutics

Oxford scientists capture genome’s structure in unprecedented detail

On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…

Read More Oxford scientists capture genome’s structure in unprecedented detailContinue

Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Biotechnology | Therapeutics

Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost

On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…

Read More Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower costContinue

Successful bone regeneration using stem cells derived from fatty tissue
Biotechnology | Disease | Non-Profit Research | Stem Cell | Therapeutics

Successful bone regeneration using stem cells derived from fatty tissue

On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…

Read More Successful bone regeneration using stem cells derived from fatty tissueContinue

FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
Biotechnology | Disease | FDA | Therapeutics

FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science

On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…

Read More FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber scienceContinue

CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
Biotechnology | Clinical Research | Disease | Neurology | Non-Profit Research | Therapeutics

CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities

On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…

Read More CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communitiesContinue

Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
Biotechnology | Clinical Research | CRO | Therapeutics

Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion

On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…

Read More Thermo Fisher to buy clinical services provider Clario for up to $9.4 billionContinue

Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
Artificial Intelligence | Biotechnology | Disease | Genomics | Therapeutics

Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus

On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…

Read More Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virusContinue

Rice launches Brain Institute to accelerate discoveries in brain science and health
Biotechnology | Neurology | Therapeutics

Rice launches Brain Institute to accelerate discoveries in brain science and health

On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…

Read More Rice launches Brain Institute to accelerate discoveries in brain science and healthContinue

Lilly partners with Nvidia on AI supercomputer to speed up drug development
Artificial Intelligence | Biotechnology | FDA | Pharmaceutical | Therapeutics

Lilly partners with Nvidia on AI supercomputer to speed up drug development

On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…

Read More Lilly partners with Nvidia on AI supercomputer to speed up drug developmentContinue

AI-powered diabetes prevention program shows similar benefits to those led by people
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Disease | Medical Device | Therapeutics

AI-powered diabetes prevention program shows similar benefits to those led by people

On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…

Read More AI-powered diabetes prevention program shows similar benefits to those led by peopleContinue

Rebalancing the Gut: How AI Solved a 25-Year Crohn’s Disease Mystery
Artificial Intelligence | Biotechnology | Disease | Genomics | Therapeutics

Rebalancing the Gut: How AI Solved a 25-Year Crohn’s Disease Mystery

On Oct. 27, 2025, researchers at University of California San Diego School of Medicine (UC San Diego) have…

Read More Rebalancing the Gut: How AI Solved a 25-Year Crohn’s Disease MysteryContinue

Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
Biotechnology | Neurology | Therapeutics

Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion

On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…

Read More Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 BillionContinue

Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
Biotechnology | Ophthalmogy | Therapeutics

Lilly to Acquire Adverum Biotechnologies for $12.47 per Share

On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…

Read More Lilly to Acquire Adverum Biotechnologies for $12.47 per ShareContinue

Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
Biotechnology | Pharmaceutical | Therapeutics

Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion

On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…

Read More Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billionContinue

South Carolina Department of Public Health Confirms Measles Outbreak
Biotechnology | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine

South Carolina Department of Public Health Confirms Measles Outbreak

On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…

Read More South Carolina Department of Public Health Confirms Measles OutbreakContinue

Pigs developed to be resistant to deadly virus
Biotechnology | Genomics | Infectious Disease | Non-Profit Research | Therapeutics | Veterinary

Pigs developed to be resistant to deadly virus

On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…

Read More Pigs developed to be resistant to deadly virusContinue

Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
Biotechnology | Pharmaceutical | Therapeutics | Vaccine

Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia

On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…

Read More Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, VirginiaContinue

Glaukos Announces FDA Approval of Epioxa™
Biotechnology | FDA | Ophthalmogy | Therapeutics

Glaukos Announces FDA Approval of Epioxa™

On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…

Read More Glaukos Announces FDA Approval of Epioxa™Continue

The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
Biotechnology | Genomics | Non-Profit Research | Stem Cell | Therapeutics

The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients

On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…

Read More The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patientsContinue

ACG to invest $200 million in U.S. hard-shell capsule manufacturing
Biotechnology | CMO | Pharmaceutical | Therapeutics

ACG to invest $200 million in U.S. hard-shell capsule manufacturing

On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…

Read More ACG to invest $200 million in U.S. hard-shell capsule manufacturingContinue

Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
Biotechnology | Medicine | Pharmaceutical | Therapeutics

Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales

On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…

Read More Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug salesContinue

China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
Biotechnology | Disease | Oncology | Therapeutics

China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche

On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…

Read More China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with RocheContinue

Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
Medical Device | Neurology | Therapeutics

Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million

On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…

Read More Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 millionContinue

FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
Biotechnology | Cardiology | FDA | Therapeutics

FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes

On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…

Read More FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetesContinue

FDA unveils drugs to receive expedited review in support of ‘national priorities’
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics

FDA unveils drugs to receive expedited review in support of ‘national priorities’

On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…

Read More FDA unveils drugs to receive expedited review in support of ‘national priorities’Continue

Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
Biotechnology | Diagnostics | Genomics | Therapeutics

Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique

On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…

Read More Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing techniqueContinue

Page navigation

Previous PagePrevious 1 2 3 4 … 115 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search